Tariffs Simulator (BETA)
Chat OEC
Company Explorer
Tree map
Stacked
Network
Map
Scatter
Exports In 2023, South Africa exported $51M in Vaccines, blood, antisera, toxins and cultures, making it the 52nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 235th most exported product in South Africa. The main destination of Vaccines, blood, antisera, toxins and cultures exports from South Africa are: Zimbabwe ($6.83M), Zambia ($6.52M), Botswana ($6.25M), Namibia ($4.07M), and Saudi Arabia ($2.92M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of South Africa between 2022 and 2023 were Saudi Arabia ($2.49M), Zimbabwe ($1.78M), and Indonesia ($1.44M).
Imports In 2023, South Africa imported $442M in Vaccines, blood, antisera, toxins and cultures, becoming the 50th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 39th most imported product in South Africa. South Africa imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($73.3M), France ($67.9M), Ireland ($61.1M), Germany ($58.6M), and Belgium ($39M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for South Africa between 2022 and 2023 were India ($9.62M), United States ($5.84M), and Switzerland ($4.49M).
